Eprosartan
Cat. No.：YN322733
| 产品名称: | Eprosartan |
| CAS No.: | 133040-01-4 |
| Chemical Name: | (αE)-α-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; (E)-2-Butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic Acid; Navixen; SKB 108566; SKF 108566; Teveten; |
| Synonyms: | SKF-108566J free base |
| 分子量: | 暂无 |
| 分子式: | 暂无 |
| SMILES: | 暂无 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Eprosartan (SKF-108566J free base) 是一种选择性，竞争性，非肽和具有口服活性的血管紧张素 II 受体 (angiotensin II receptor) 拮抗剂，可用作降压剂。Eprosartan 结合血管紧张素 II 受体，在大鼠和人类肾上腺皮质膜中的IC50值分别为 9.2 nM 和 3.9 nM。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Edwards, R.M., et al.: J. Pharmacol. Exp. Ther., 260, 175 (1992), Schambye, H.T., et al.: Mol. Pharmacol., 47, 425 (1995), Tenero, D., et al.: Biopharma Drug Dispos., 19, 351 (1998), Elliott, W.J., et al.: J. Hum. Hypertens., 13, 413 (1999)
